Askandal, Nur-aiza G.

HRN: 05-11-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2025
CEFUROXIME 500MG (TAB)
08/14/2025
08/21/2025
PO
1 Tablet
BID
CAP LR
Remove - Pending Acceptance
08/18/2025
CEFTRIAXONE 1G (VIAL)
08/18/2025
08/25/2025
IV
2g
OD
CAP-MR
Remove - Pending Acceptance
08/18/2025
AZITHROMYCIN 500MG TABLET (TAB)
08/18/2025
08/22/2025
PO
500mg
OD
CAP MR
Remove - Pending Acceptance
08/22/2025
CO-AMOXICLAV 625MG (TAB)
08/22/2025
08/25/2025
PO
625mg
TID
CAP MR
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: